[JANX] QoQ Quarter Result on 31-Dec-2023 [#Q4]

Stock
[JANX] Janux Therapeutics, Inc.
Announcement Date
08-Mar-2024
Financial Year
2023
Quarter
31-Dec-2023 [#Q4]
Profit Trend
QoQ- -1.64%
YoY- -4.42%
Quarter Report
JANX's Result
JANX's Financial Summary
View:
Show?
Quarter Result
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
Revenue 8,897 1,252 2,461 2,517 1,057 2,048 2,845 113.99%
PBT -5,959 -14,760 -11,758 -11,568 -17,508 -17,459 -16,065 -48.40%
Tax 0 489 953 -500 349 -453 -4,805 -
NP -5,959 -14,760 -11,758 -11,568 -17,508 -17,459 -11,260 -34.59%
Tax Rate - - - - - - - -
Total Cost 14,856 16,012 14,219 14,085 18,565 19,507 14,105 3.52%
Ratio Analysis
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
NP Margin -66.98 -1,178.91 -477.77 -459.59 -1,656.39 -852.49 -395.78 -69.43%
Per Share
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
EPS -0.11 -0.30 -0.25 -0.25 -0.42 -0.42 -0.27 -45.07%
EPS Diluted -0.11 -0.30 -0.25 -0.25 -0.42 -0.42 -0.27 -45.07%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.